Has Mesfin Lemma, MD received payments from drug or device companies?

Yes. Drug and device makers reported $46,946 in general payments to Mesfin Lemma, MD across 46 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mesfin Lemma, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mesfin Lemma, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mesfin Lemma, MD

Orthopaedic Surgery of the Spine · Baltimore, MDNPI 1366410193

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $29,201 of the $46,946 with a category attached, or 62.2%. 5 manufacturers reported payments, led by Orthofix Medical, Inc. at 54.7% of the total. Reporting peaked in 2021 at $16,088 and has fallen 75.8% since, to $3,889 in 2025.

$46,946in general payments, 2019–2025

Across 46 payments — averaging $1020.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Orthofix Medical, Inc.$26K
Altus Partners. LLC$13K
Stryker$5K
Alphatec Spine, Inc$2K
Zavation Medical Products, LLC$1K

What the payments were for

Royalty or licence$29,20162%
Consulting fees$10,25022%
Travel & lodging$6,69114%
Food & beverage$8032%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Orthofix Medical, Inc.	20	$25,694
Altus Partners. LLC	2	$12,608
Stryker	10	$4,896
Alphatec Spine, Inc	7	$2,305
Zavation Medical Products, LLC	7	$1,443

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,946 in reported general payments places this provider in the 80th percentile of 49 orthopaedic surgery of the spine providers in Maryland.

See all orthopaedic surgery of the spine providers in Maryland →

Medicare billing

Part B allowed, 2024

$266,788

Medicare patients

344

Services billed

890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery of the spine in Baltimore

John CarboneBaltimore$25M
Steven LudwigBaltimore$2.7M
Paul McAfeeBaltimore$2.2M
Amit JainBaltimore$250K
Daniel GelbBaltimore$40K
Charles EdwardsBaltimore$17K
Zan NaseerBaltimore$16K
Maksim ShlykovBaltimore$14K
Syed KarimBaltimore$12K
David FalkBaltimore$10K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →